T1	Chemical	0 212	Selumetinib ( AZD6244 , ARRY-142886 ) is a potent and selective inhibitor of MEK1/2 which has demonstrated significant efficacy in combination with docetaxel in patients with KRAS mutant pretreated advanced NSCLC
T2	Disease	213 214	.
R1	isEquivalentTo	Arg1:T2	Arg2:T1
